Placebo (IM)

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Walter Reed Army Institute of Research (WRAIR)

Conditions

Acute Stress ReactionFear of SpidersHIV InfectionsInfluenza

Phase 1

Higher Dose Intradermal H5 Vaccine

CompletedNCT00439335

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2007-03-31End: 2008-02-29Updated: 2013-04-09

A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

CompletedNCT04826094

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2021-03-15End: 2024-02-13Updated: 2025-03-26

Phase 4

The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Performance Outcomes

RecruitingNCT06982183

Walter Reed Army Institute of Research (WRAIR)Acute Stress Reaction, Fear of Spiders

Start: 2025-05-27End: 2026-09-30Target: 110Updated: 2025-07-15

Related Papers

Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermally.

2025-02-011 citations

Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.

2012-08-1317 citations